Nigerian Public Alert 83: NAFDAC Notifies on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
Nigerian Public Alert 83: The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the detection of a suspected counterfeit medicinal product found in the Nigerian market that infringes on the approved marketing authorization of Pulmicort® (Budesonide) manufactured by AstraZeneca. The information was provided to NAFDAC by AstraZeneca following market surveillance activities.